Recent advances in natural products targeting α-synuclein aggregation or clearance in Parkinson's disease
Parkinson's disease is a neurodegenerative disorder characterized by the accumulation of misfolded α-synuclein fibrils, leading to the formation of Lewy bodies. Currently, no effective treatment exists to halt the progression of the disease. Only symptomatic relief and dopamine replacement ther...
Saved in:
Main Authors: | Jay Gupta (Author), Koneni V. Sashidhara (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The potential of natural products to inhibit abnormal aggregation of α-Synuclein in the treatment of Parkinson's disease
by: Kaixia Yang, et al.
Published: (2024) -
Plant Extracts and Phytochemicals Targeting α-Synuclein Aggregation in Parkinson's Disease Models
by: Hayate Javed, et al.
Published: (2019) -
Development of Small Molecules Targeting α-Synuclein Aggregation: A Promising Strategy to Treat Parkinson's Disease
by: Samuel Peña-Díaz, et al.
Published: (2023) -
Corynoxine B targets at HMGB1/2 to enhance autophagy for α-synuclein clearance in fly and rodent models of Parkinson's disease
by: Qi Zhu, et al.
Published: (2023) -
Exosomal DNA Aptamer Targeting α-Synuclein Aggregates Reduced Neuropathological Deficits in a Mouse Parkinson's Disease Model
by: Xiaoxi Ren, et al.
Published: (2019)